Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Medical - Diagnostics & Research Industry — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.0:1
Daily Buy & Sell Volume
Mar 3, 2026
Sale
Shares
680
Price
$498.14
Total Value
$338.74K
Shares Held After
127,405
% of Holdings
0.5%
Mar 3, 2026
Sale
Shares
480
Price
$496.84
Total Value
$238.48K
Shares Held After
128,085
% of Holdings
0.4%
Mar 3, 2026
Sale
Shares
360
Price
$495.29
Total Value
$178.30K
Shares Held After
128,565
% of Holdings
0.3%

IDEXX LABORATORIES INC /DE (IDXX)

Hunt Nimrata — Executive Vice President
Mar 3, 2026
Sale
Shares
1,758
Price
$634.57
Total Value
$1.12M
Shares Held After
18,141
% of Holdings
8.8%

EXAGEN INC. (XGN)

ABALLI JOHN — Director
Mar 3, 2026
Sale
Shares
15,698
Price
$3.62
Total Value
$56.83K
Shares Held After
687,299
% of Holdings
2.2%

GRAIL, Inc. (GRAL)

Freidin Aaron — Chief Financial Officer
Mar 2, 2026
Sale
Shares
438
Price
$51.86
Total Value
$22.72K
Shares Held After
309,622
% of Holdings
0.1%

GRAIL, Inc. (GRAL)

Freidin Aaron — Chief Financial Officer
Mar 2, 2026
Sale
Shares
9,135
Price
$50.09
Total Value
$457.53K
Shares Held After
310,060
% of Holdings
2.9%

GRAIL, Inc. (GRAL)

RAGUSA ROBERT P — Director
Mar 2, 2026
Sale
Shares
1,717
Price
$51.84
Total Value
$89.01K
Shares Held After
650,525
% of Holdings
0.3%

GRAIL, Inc. (GRAL)

RAGUSA ROBERT P — Director
Mar 2, 2026
Sale
Shares
35,787
Price
$50.09
Total Value
$1.79M
Shares Held After
652,242
% of Holdings
5.2%

GRAIL, Inc. (GRAL)

Ofman Joshua J. — President
Mar 2, 2026
Sale
Shares
16,223
Price
$50.09
Total Value
$812.53K
Shares Held After
436,508
% of Holdings
3.6%

GRAIL, Inc. (GRAL)

Ofman Joshua J. — President
Mar 2, 2026
Sale
Shares
779
Price
$51.75
Total Value
$40.31K
Shares Held After
452,731
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
10,000
Price
$212.52
Total Value
$2.13M
Shares Held After
117,185
% of Holdings
7.9%
Mar 2, 2026
Sale
Shares
365
Price
$201.18
Total Value
$73.43K
Shares Held After
156,607
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
2,463
Price
$200.24
Total Value
$493.19K
Shares Held After
156,972
% of Holdings
1.5%
Mar 2, 2026
Sale
Shares
1,122
Price
$199.17
Total Value
$223.47K
Shares Held After
159,435
% of Holdings
0.7%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 2, 2026
Sale
Shares
100
Price
$202.85
Total Value
$20.29K
Shares Held After
262,194
% of Holdings
0.0%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 2, 2026
Sale
Shares
100
Price
$201.20
Total Value
$20.12K
Shares Held After
262,294
% of Holdings
0.0%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 2, 2026
Sale
Shares
2,400
Price
$200.42
Total Value
$481.01K
Shares Held After
262,394
% of Holdings
0.9%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 2, 2026
Sale
Shares
470
Price
$198.50
Total Value
$93.29K
Shares Held After
264,794
% of Holdings
0.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
475
Price
$200.97
Total Value
$95.46K
Shares Held After
150,023
% of Holdings
0.3%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
1,594
Price
$200.11
Total Value
$318.97K
Shares Held After
150,498
% of Holdings
1.0%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
931
Price
$198.83
Total Value
$185.11K
Shares Held After
152,092
% of Holdings
0.6%
Version: v26.3.23